Beijing Hotgen Biotech Co Ltd (688068) — Cash Flow Quality Index
Beijing Hotgen Biotech Co Ltd (688068) has a Cash Flow Quality Index of -1.95x as of September 2024. Operating cash flow of CN¥-5.53 Million is below net income of CN¥2.83 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 688068 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Beijing Hotgen Biotech Co Ltd Cash Flow Quality Index (2016–2023)
Historical Cash Flow Quality Index for Beijing Hotgen Biotech Co Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Beijing Hotgen Biotech Co Ltd cash conversion from operations.
Annual Cash Flow Quality Index for Beijing Hotgen Biotech Co Ltd (2016–2023)
Year-by-year earnings quality comparison for Beijing Hotgen Biotech Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -1.69x | CN¥-25.39 Million | CN¥15.05 Million | ▼ -259.4% |
| 2022 | 1.06x | CN¥978.75 Million | CN¥925.12 Million | ▼ -11.9% |
| 2021 | 1.20x | CN¥2.64 Billion | CN¥2.20 Billion | ▼ -18.8% |
| 2020 | 1.48x | CN¥164.62 Million | CN¥111.30 Million | ▲ +157.7% |
| 2019 | 0.57x | CN¥19.37 Million | CN¥33.75 Million | ▼ -49.7% |
| 2018 | 1.14x | CN¥55.04 Million | CN¥48.19 Million | ▲ +49.7% |
| 2017 | 0.76x | CN¥22.95 Million | CN¥30.07 Million | ▼ -51.7% |
| 2016 | 1.58x | CN¥45.54 Million | CN¥28.80 Million | — |